William L. Matier
53Patents
10h-index
16Co-inventors
75Inventor score
Filing activity: Aug 4, 1975 → Jun 18, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4060615A | 2-Piperazinyl-6,7-dimethoxyquinazolines | Chemistry; Metallurgy | 97 | Expired |
| US4052455A | Styrylamidines | Human Necessities | 48 | Expired |
| US4130663A | Styrylamidines | Human Necessities | 48 | Expired |
| US4895934A | Process for the preparation of clindamycin phosphate | Chemistry; Metallurgy | 28 | Expired |
| US5059620A | Aryl substituted aminomethyl benzene derivatives | Chemistry; Metallurgy | 25 | Expired |
| US4849515A | Clindamycin-2-phosphoryl benzylate | Chemistry; Metallurgy | 20 | Expired |
| US4562201A | Aminomethyl benzanilides | Chemistry; Metallurgy | 15 | Expired |
| US4402974A | Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents | Human Necessities | 13 | Expired |
| US4466965A | Phthalazine compounds, compositions and use | Chemistry; Metallurgy | 11 | Expired |
| US4454154A | Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents | Human Necessities | 11 | Expired |
| US7678829B2 | Oculoselective drugs and prodrugs | Emerging Cross-Sectional Technologies | 10 | Active |
| US4990668A | Optically active aryloxypropanolamines and arylethanolamines | Chemistry; Metallurgy | 10 | Expired |
| US4578403A | Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents | Human Necessities | 8 | Expired |
| US4582855A | Aromatic and esters of hydroxypropylamines | Chemistry; Metallurgy | 8 | Expired |
| US4748184A | Aryl substituted aminomethyl benzene derivatives having antiarrhythmic utility | Chemistry; Metallurgy | 7 | Expired |
| US7589107B2 | Amelioration of vitrectomy-induced cataracts | Human Necessities | 7 | Active |
| US4455317A | Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents | Human Necessities | 6 | Expired |
| US4243681A | Alkylthiophenoxypropanolamines and pharmaceutical compositions and uses thereof | Chemistry; Metallurgy | 6 | Expired |
| US4692446A | Esters of aryloxypropanolamine derivatives and medicinal uses | Chemistry; Metallurgy | 6 | Expired |
| US4897417A | Prodrugs of 3,4-hydroxy benzoyloxypropanolamines | Chemistry; Metallurgy | 5 | Expired |
| US4623652A | Esters of thiadiazole oxypropanolaine derivatives and pharmaceutical uses | Chemistry; Metallurgy | 5 | Expired |
| US5536749A | Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents | Human Necessities | 5 | Expired |
| US4508725A | Esters of 3-(3-substituted-amino-2-hydroxypropoxy)-4-substituted-1,2,5-thiadiazole derivatives | Chemistry; Metallurgy | 4 | Expired |
| US4804677A | Esters of aryloxypropanolamine derivatives | Chemistry; Metallurgy | 4 | Expired |
| US4966914A | Oculoselective beta-blockers as antiglaucoma agents | Chemistry; Metallurgy | 4 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.